Clincosm LogoSign in Get a demo

Leukemia

Showing 26 - 50 of 1,510
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Acute Lymphoblastic Leukemia Trial in New York (gene-modified T cells targeted)

Active, not recruiting
  • Leukemia
  • Acute Lymphoblastic Leukemia
  • gene-modified T cells targeted
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 1, 2023

Drug/Agent Toxicity by Tissue/Organ, Leukemia, MDS Trial in Chicago, Kankakee (amifostine trihydrate, cytarabine, mitoxantrone

Withdrawn
  • Drug/Agent Toxicity by Tissue/Organ
  • +3 more
  • amifostine trihydrate
  • +2 more
  • Chicago, Illinois
  • +3 more
Jan 31, 2023

Hematologic Malignancy, Blood Cancer, Lymphoma Trial in Boston (Palliative Care, Usual Care)

Recruiting
  • Hematologic Malignancy
  • +4 more
  • Palliative Care
  • Usual Care
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jan 24, 2023

Agricultural Health Study Cohort Pesticide Exposure Study

Completed
  • Multiple Myeloma
  • +3 more
    • Iowa City, Iowa
    • +1 more
    Jan 25, 2023

    Immunophenotyping of Blast Cells and Immune Effector Cells in

    Completed
    • Leukemia
    • Blood and Marrow sample
    • Marseille, France
      Assistance Publique - Hopitaux de Marseille
    Jan 23, 2023

    Leukemia, Multiple Myeloma, Myelodysplastic Syndrome Trial in New York (biological, procedure, radiation, drug)

    Active, not recruiting
    • Leukemia
    • +3 more
    • Palifermin
    • +6 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 23, 2023

    Chronic Graft-versus-Host-Disease, Allogeneic Hematopoietic Stem Cell Transplantation, Leukemia Trial

    Not yet recruiting
    • Chronic Graft-versus-Host-Disease
    • +4 more
      • (no location specified)
      Jan 11, 2023

      Solid Tumor, Leukemia Trial in Paris (Solid tumor and CT DNA)

      Recruiting
      • Solid Tumor
      • Leukemia
      • Solid tumor and CT DNA
      • Paris, Villejuif, France
        Gustave Roussy
      Jan 19, 2023

      Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine, PDR001, MBG453)

      Active, not recruiting
      • Leukemia
      • +7 more
      • Boston, Massachusetts
      • +10 more
      Jan 19, 2023

      Leukemia, Lymphoma, Cardiotoxicity Trial in Philadelphia

      Completed
      • Leukemia
      • +4 more
        • Philadelphia, Pennsylvania
          Abramson Cancer Center of the University of Pennsylvania
        Jan 19, 2023

        Bone Marrow Cancer, Leukemia, Lymphoma Trial in Philadelphia (Virtual reality, Environmental changes)

        Enrolling by invitation
        • Bone Marrow Cancer
        • +4 more
        • Virtual reality
        • Environmental changes
        • Philadelphia, Pennsylvania
          Thomas Jefferson University Hospital
        Jan 9, 2023

        Leukemia, Lymphoma Trial in United States (SCRI-CAR22v2)

        Recruiting
        • Leukemia
        • Lymphoma
        • SCRI-CAR22v2
        • Los Angeles, California
        • +4 more
        Jan 18, 2023

        Solid Tumor Malignancy, Hematologic Malignancy, Leukemia Trial run by the NCI (mrna 1273 injection)

        Recruiting
        • Solid Tumor Malignancy
        • +4 more
        • mRNA-1273
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 14, 2023

        Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

        Suspended
        • Juvenile Myelomonocytic Leukemia
        • +27 more
        • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
        • +2 more
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        Jan 11, 2023

        Leukemia Trial in United States (mercaptopurine, methotrexate, tretinoin)

        Completed
        Has Results
        • Leukemia
        • Scottsdale, Arizona
        • +209 more
        Dec 14, 2022

        Leukemia Trial in United States (arsenic trioxide, gemtuzumab ozogamicin, mercaptopurine)

        Completed
        Has Results
        • Leukemia
        • arsenic trioxide
        • +4 more
        • Roseville, California
        • +191 more
        Dec 14, 2022

        Leukemia, Relapsed, Myeloid Trial in Netherlands, Switzerland (MP0533 (multispecific DARPin CD3 Engager Targeting CD33, CD123

        Recruiting
        • Leukemia
        • +3 more
        • MP0533 (multispecific DARPin CD3 Engager Targeting CD33, CD123 and CD70)
        • Amsterdam, Netherlands
        • +4 more
        Jan 4, 2023

        Leukemia Trial in Portland (cyclophosphamide, cytarabine, dexamethasone)

        Terminated
        Has Results
        • Leukemia
        • Portland, Oregon
          OHSU Knight Cancer Institute
        Dec 13, 2022

        Blood Samples to Identify Biomarkers of Busulfan

        Active, not recruiting
        • Leukemia
        • +4 more
          • Seattle, Washington
            University of Washington
          Jan 4, 2023

          Leukemia Trial in Houston (Cyclophosphamide, Vincristine, Blinatumomab)

          Not yet recruiting
          • Leukemia
          • Houston, Texas
            M D Anderson Cancer Center
          Dec 23, 2022

          Immunodeficiency, Immunosuppression, HIV Trial in La Jolla (Access to Cue Health COVID-19 Remote testing and treatment for

          Recruiting
          • Immunodeficiency
          • +8 more
          • Access to Cue Health COVID-19 Remote testing and treatment for COVID-19
          • La Jolla, California
            Scripps Research
          Dec 22, 2022

          Leukemia Trial (Donor Enriched Activated Natural Killer Cell Infusion)

          Withdrawn
          • Leukemia
          • Donor Enriched Activated Natural Killer Cell Infusion
          • (no location specified)
          Dec 20, 2022

          Developing Cardiotoxicity After Receiving Chemotherapy for

          Recruiting
          • Breast Cancer
          • +2 more
          • Cardiac Imaging
          • Data Collection
          • MontrĂ©al, Quebec, Canada
          • +2 more
          Dec 20, 2022

          Leukemia, T-cell Prolymphocytic Leukemia (T-PLL), Cancer Trial in Worldwide (Venetoclax, Ibrutinib)

          Completed
          Has Results
          • Leukemia
          • +2 more
          • Boston, Massachusetts
          • +14 more
          Nov 23, 2022

          Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma

          Recruiting
          • Clinical Stage I Cutaneous Melanoma AJCC v8
          • +33 more
          • Informational Intervention
          • +4 more
          • Los Angeles, California
          • +4 more
          Dec 14, 2022